XBP1s Is an Anti-lipogenic Protein
2016 · Journal of Biological Chemistry · 71 citations
https://doi.org/10.1074/jbc.m116.728949
Y
Yingjiang Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
3.8K
Citations
25
h-index
31
i10-index
Yingjiang Zhou is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Endoplasmic Reticulum Stress and Disease & Adipose Tissue and Metabolism & Pancreatic function and diabetes. The author has an h-index of 25, co-authored 37 publications.
Papers by this author
worksDiscovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)
2015 · Scientific Reports · 68 citations
https://doi.org/10.1038/srep17391
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
2016 · Journal of Pharmacokinetics and Pharmacodynamics · 47 citations
https://doi.org/10.1007/s10928-016-9481-1
Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction
2020 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-020-60290-1
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease
2025 · Hepatology Communications · 8 citations
https://doi.org/10.1097/hc9.0000000000000637
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies
2022 · SLAS DISCOVERY · 5 citations
https://doi.org/10.1016/j.slasd.2021.10.015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat